VRT — Vertiv Holdings Co

The tape is negative even though the business is not. As of 2026-09-13, VRT was down 8.37% in one week, 10.85% in one month and 15.13% in three months, with a roughly 9.6% single-day drop on 2026-09-09. The triggers were sentiment, not earnings: the 2026-09-02 announcement of the ~$1.45B upfront (up to $2.6B with earnouts) UIG acquisition came with no disclosed revenue, backlog or cash-flow metrics, and the July 29 Q2 revenue miss ($3.27B vs $3.38B consensus) is still being read as evidence of execution friction. Add $128.2M of trailing-12-month insider selling with zero buys and the Pomerantz class-action investigation noise from late August, and the marginal seller is winning. Offsetting this, the company beat on Q2 adjusted EPS ($1.52 vs $1.43) and RAISED full-year adjusted EPS guidance to $6.65-$6.75, and the analyst consensus is still Buy with a $368.75 average target - a gap that tells you targets are stale, not that the market is wrong.

Revenue growth is decelerating from a hot peak but is nowhere near rolling over: +19.0% YoY in Q3 2024, +25.8% Q4 2024, +24.2% Q1 2025, +35.1% Q2 2025, +29.0% Q3 2025, +22.7% Q4 2025, +30.1% Q1 2026 and +24.1% Q2 2026 ($3.274B vs $2.638B). The sequential dip from Q4 2025's $2.880B to Q1 2026's $2.650B mirrors the prior-year Q4-to-Q1 pattern ($2.346B to $2.036B), so that is seasonality, not decay. Margins are the real story and they are still expanding on a YoY basis every single quarter: operating margin of 14.63% (Q3 2023) -> 15.51% -> 12.36% (Q1 2024 trough) -> 16.98% -> 18.23% -> 19.75% -> 14.22% (Q1 2025) -> 17.17% -> 19.31% -> 20.85% -> 16.61% (Q1 2026) -> 19.48% (Q2 2026). Gross margin on Q2 went from 32.2% (Q2 2025) to 37.7% (Q2 2026) - a 550bp jump that is the clearest evidence of pricing power in high-density liquid cooling. Diluted EPS has gone from -$0.016 (Q1 2024) to $1.27 in Q2 2026, with the one caveat that Q2 GAAP of $1.27 sits $0.25 below the $1.52 adjusted figure, so roughly $100M of intangible amortization/SBC is being added back. Free cash flow has inflected hard: TTM FCF is $2.924B versus $1.239B for the prior-year TTM window, with Q2 2026 alone at $925.3M (vs $277.0M in Q2 2025). Verdict: a structural growth story with genuine margin expansion, currently showing a modest deceleration and one quarter of top-line timing friction - an inflection in the narrative, not a break in the trend.

Expensive on absolute and asset-based measures, merely full on earnings. As of 2026-09-13 at $257.06: trailing P/E 56.9x versus a 5-year average of 61.4x (so actually a slight DISCOUNT to its own recent history), forward P/E roughly 38x on the FY2026 adjusted EPS guidance midpoint of $6.70, PEG 0.51 (which screens cheap against growth), price/sales 8.62x versus a 5-year average of 3.34x (a 2.6x premium to its own history), price/book 20.8x, and EV/EBITDA 40.2x. Read that mix honestly: the earnings multiple is roughly in line with history and the growth-adjusted multiple is attractive, but the sales and book multiples say the market has permanently re-rated the business on the assumption that AI-era mid-20s growth and ~20%+ operating margins are the new baseline. If that baseline holds, 38x forward earnings is defensible. If growth settles into the low teens, this is a 20x-forward-earnings stock and the downside is large. This is a 'rich but not obviously bubble-level given the growth' situation - the honest label is expensive, with the caveat that the trailing P/E is below its own 5-year average.

The key insight as of 2026-09-13 is that this drawdown is pure multiple compression, not estimate cuts. Analysts RAISED FY2026 adjusted EPS guidance to $6.65-$6.75 on July 29, 2026, while the stock fell from near $380 in May 2026 to $257.06. That means the market has already de-rated the forward multiple from roughly 55x to roughly 38x FY2026E and roughly 31x my FY2027E estimate of ~$8.55. In other words, the stock is now priced for a deceleration to high-teens EPS growth - it is NOT priced for the 24% revenue growth the company just printed. That creates an asymmetric setup around the late-October/early-November Q3 2026 report: if the Q2 revenue timing shift reverses and the raised EPS guide holds, the multiple has room to re-expand toward 40-42x and the stock can run without any estimate increase at all. If Q3 delivers a SECOND consecutive top-line miss, the 'peak growth' narrative hardens and 30x becomes the ceiling rather than the floor. Watch orders/backlog commentary more than the revenue line itself.

Bearish trend, neutral momentum, sitting on a decision line. As of 2026-09-13: RSI(14) 45.14 - neither oversold nor overbought, so there is no capitulation washout to buy. Price was 3.49% below the 20-day (~$266), 7.78% below the 50-day (~$279), and 0.91% below the 200-day (~$259), producing a bearish short-term stack with the stock pinned right at its long-term trend line. The six-month return of -0.7% against the three-month return of -15.13% tells you this is a sharp recent break inside a longer sideways range rather than a multi-quarter downtrend - but the one-week -8.37% and one-month -10.85% show the sellers are in control right now. Entry-timing implication: this is not a falling-knife bounce trade and it is not an oversold gift. The cleanest setups are either (a) a reclaim of the 50-day near $279, which would confirm the UIG overhang is being absorbed, or (b) a genuine flush below ~$245 with RSI under 30. Buying in between means paying $257 for a stock whose own 200-day line is $259 and whose 50-day is $279 - you get no technical edge at the current price.

• Hyperscaler AI capex cycle: structural demand for liquid cooling and high-density power architecture necessary for NVIDIA-class clusters remains the core tailwind, but the market is now hyper-sensitive to any hint of a digestion pause - a single cautious capex comment from a major cloud customer can move VRT more than its own earnings.
• Data center regulation and permitting friction: state and local pushback (e.g. Massachusetts executive actions requiring strict municipal approval for new data center construction) lengthens physical buildout timelines and can shift Vertiv's revenue recognition to the right even when orders are healthy.
• Interest rates and high-beta risk-off rotation: VRT's beta of 2.075 makes it a leveraged expression of the AI infrastructure trade; rising long rates compress the multiple on long-duration growth cash flows and any broad market de-risking hits VRT harder than the index.
• Power availability and grid constraints: utility interconnection queues and switchgear lead times cap how quickly data center capacity can actually be energized - which is simultaneously a headwind to VRT's delivery schedule and the strategic rationale for the UIG microgrid/switchgear acquisition.
• Supply chain and complex project execution: Q2 2026's revenue miss was attributed to timing shifts on complex projects plus supply constraints, and long lead times on large power and thermal systems mean revenue recognition will stay lumpy quarter-to-quarter regardless of underlying demand.

• Q3 2026 earnings (late October/early November 2026): the single most important checkpoint - does the Q2 project-timing shift reverse, does the $6.65-$6.75 adjusted EPS guide hold or rise, and what does order/backlog commentary say about 2027.
• UIG acquisition closing and financial disclosure: the 2026-09-02 deal carried no published revenue, backlog or cash-flow metrics; any subsequent disclosure that frames the price paid against real numbers would remove the largest overhang, while a delay or an earnout revision would worsen it.
• Continued hyperscaler and NVIDIA roadmap announcements: new liquid-cooling design wins or a formal shift to higher-density racks (e.g. 200kW+ per rack) would validate the margin expansion thesis and could trigger multiple re-expansion.
• Management commentary at investor conferences following the September 2026 Goldman Sachs Communacopia + Technology Conference - incremental color on order intake and UIG integration timing.
• Resolution or escalation of the Pomerantz LLP and other class-action investigations launched in late August 2026; a quiet dismissal is a non-event, a formal filing introduces a headline and legal-cost overhang.

• Valuation risk is the dominant risk: 8.62x sales versus a 5-year average of 3.34x, 20.8x book and 40.2x EV/EBITDA mean that a shift in growth expectations from mid-20s to low-teens could take the stock to a ~20x forward P/E - roughly $170 on FY2027E EPS of $8.55 - without any deterioration in the actual business.
• End-market concentration in hyperscale AI capex: Vertiv's order book is effectively levered to a handful of cloud customers' buildout schedules, so one customer's digestion year becomes Vertiv's down year.
• Execution risk has now shown up twice: a sequential revenue decline from $2.880B (Q4 2025) to $2.650B (Q1 2026) and then a Q2 2026 revenue miss ($3.27B vs $3.38B expected). A third miss would harden the 'peak growth' narrative.
• UIG acquisition risk: ~$1.45B upfront cash on a company with $2.81B of cash on the balance sheet (up to $2.6B with earnouts), with zero disclosed revenue, backlog or cash-flow metrics for the target - i.e., a genuine information vacuum around the price being paid, plus integration and overpayment risk.
• Insider and legal signals: $128.2M of insider sales over the trailing 12 months with zero insider buying, alongside fresh class-action law firm investigations, is a pattern worth respecting even when the fundamentals look intact.
• Competitive intensity: Schneider Electric, Eaton, nVent and Delta are all pushing into data center thermal and power, and there is a long-run risk that large customers or silicon vendors vertically integrate cooling - both would pressure Vertiv's 37.7% gross margin.

Yes, this is a reasonable place to own the AI infrastructure buildout - but buy it with the multiple risk understood, not as a dip to be chased. The underlying business is genuinely strong: 24.1% YoY Q2 2026 revenue growth, operating margin up from 17.2% to 19.5% YoY, gross margin up 550bp, 18.5% ROIC, a negative accruals ratio of -3.79% (cash earnings exceeding accounting earnings), $2.92B of TTM free cash flow and effectively zero net debt ($2.94B LT debt against $2.81B cash). What you are paying for it as of 2026-09-13 - 38x FY2026 adjusted EPS and 8.6x sales - is full, which is exactly how a stock falls 32% from its high while guidance goes UP. My calculated fair value of $274 implies roughly 7% upside with meaningful downside if growth decelerates faster than expected. Own it on weakness, size it for the 2.07 beta, and watch orders rather than revenue.

Applied a 32x forward P/E - justified by ~22% forward adjusted EPS growth (a PEG near 1.45), 37.5% gross margin, 18.5% ROIC and a still-expanding operating margin, and a discount to the company's own 5-year average trailing P/E of 61.4x - to my FY2027E adjusted EPS of $8.55, which rolls forward the FY2026 guidance midpoint of $6.70 on ~20% revenue growth plus continued margin expansion, net of ~$0.16/share of forgone interest income from the cash-funded UIG deal. Cross-checks: a 9.5% WACC FCF DCF on ~$3.2B of FY2026 free cash flow yielded ~$260, and a 25-30x EV/EBITDA range on FY2026E EBITDA of ~$3.2B yielded ~$245-$290, so $274 sits mid-range rather than at an optimistic extreme.